Ulas, TurgayPaksoy, FatmaGurbuz, Didem GokcenDal, Mehmet SinanTursun, İrfanApucu, Hacı GokhanBes, Cemal2025-03-082025-03-0820121304-96231309-4025https://hdl.handle.net/11468/31111Amaç: Bu çalışmada yeni tanılı ve klinik takip altındaki metabolik sendromlu hastalarda serum ferritin düzeylerinin karşılaştırılmasını amaçladık. Materyal ve metod: NCEP ATP III kriterlerine göre yeni metabolik sendrom tanısı konan 51 hasta ile konvansiyonel insülin direnci tedavisi alan metabolik sendrom tanılı 179 hastada serum ferritin düzeyleri karşılaştırıldı.Bulgular: Serum ferritin ve HOMA-IR düzeyleri yeni metabolik sendrom tanısı alanlarda, tedavi alan diğer metabolik sendromlu hastalara göre anlamlı yüksek tespit edildi her ikisi için pBackground: The purpose of this study was to compare serum ferritin levels between newly diagnosed and clinical follow-up patients with metabolic syndrome. Methods: Fifty-one newly diagnosed patients with metabolic syndrome according to the NCEP ATP III criteria were compared 179 patients with metabolic syndrome who have receiving conventional insulin resistance therapy. Results: Ferritin and HOMA-IR levels in newly diagnosed patients with metabolic syndrome were significantly higher than clinical follow-up patients with metabolic syndrome both peninfo:eu-repo/semantics/openAccessFerritinmetabolik sendrominsülin direnciFerritinmetabolic syndromeinsulin resistanceArticle926164